Gabapentin
Product Images NDC 45865-122
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 45865-122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)
This appears to be a formula for calculating creatinine clearance in patients, adjusted for gender. It involves multiplying the patient's age in years minus 140 by their weight in kilograms, and dividing by 72 multiplied by their serum creatinine level in milligrams per deciliter. Female patients must then multiply the result by 0.85.*
Chem Structure (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)
Figure01 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)
Figure02 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)
Figure03 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)
This is a chart that shows the proportion of patients who experienced more than a 50% reduction in pain score during controlled PHN studies. The chart contains data from Study 1 and Study 2, and indicates the percentage of responders in each study. There are some markings that indicate statistical significance, including "#p< 00l" and "% p < 0.001". There is also mention of different dosages of GBP (which likely stands for Gabapentin) and a placebo (PBO) used in the studies, costing GBP 3600, GBP 1800, and GBP 2400 respectively.*
Figure4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.